Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ADCLEC.syn1 |
Trade Name | |
Synonyms | |
Drug Descriptions |
ADCLEC.syn1 comprises T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting ADGRE2 and a chimeric costimulatory receptor (CCR) targeting CLEC12A (CLL1), which potentially induce tumor cell killing (PMID: 37802054). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C200268 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ADCLEC.syn1 | ADCLEC.syn1 | 0 | 1 |